346 related articles for article (PubMed ID: 10222005)
1. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
[TBL] [Abstract][Full Text] [Related]
2. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
3. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
Morales CR; Terry ES; Zackert WE; Montine TJ; Morrow JD
Clin Chim Acta; 2001 Dec; 314(1-2):93-9. PubMed ID: 11718683
[TBL] [Abstract][Full Text] [Related]
4. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
[TBL] [Abstract][Full Text] [Related]
5. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
[TBL] [Abstract][Full Text] [Related]
6. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571
[TBL] [Abstract][Full Text] [Related]
7. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
Mori TA; Croft KD; Puddey IB; Beilin LJ
Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
[TBL] [Abstract][Full Text] [Related]
8. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
Schweer H; Watzer B; Seyberth HW; Nüsing RM
J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
[TBL] [Abstract][Full Text] [Related]
9. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
10. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
Morrow JD; Roberts LJ; Daniel VC; Awad JA; Mirochnitchenko O; Swift LL; Burk RF
Arch Biochem Biophys; 1998 May; 353(1):160-71. PubMed ID: 9578611
[TBL] [Abstract][Full Text] [Related]
11. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
Schwedhelm E; Bartling A; Lenzen H; Tsikas D; Maas R; Brümmer J; Gutzki FM; Berger J; Frölich JC; Böger RH
Circulation; 2004 Feb; 109(7):843-8. PubMed ID: 14757688
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
[TBL] [Abstract][Full Text] [Related]
13. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
Tsikas D; Suchy MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():191-201. PubMed ID: 25583542
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.
Il'yasova D; Morrow JD; Ivanova A; Wagenknecht LE
Ann Epidemiol; 2004 Nov; 14(10):793-7. PubMed ID: 15519902
[TBL] [Abstract][Full Text] [Related]
15. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans.
Helmersson J; Basu S
Prostaglandins Leukot Essent Fatty Acids; 2001 Aug; 65(2):99-102. PubMed ID: 11545626
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats.
Tong V; Teng XW; Karagiozov S; Chang TK; Abbott FS
Free Radic Biol Med; 2005 Jun; 38(11):1471-83. PubMed ID: 15890621
[TBL] [Abstract][Full Text] [Related]
17. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
[TBL] [Abstract][Full Text] [Related]
18. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
[TBL] [Abstract][Full Text] [Related]
19. Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis.
Cracowski JL; Kom GD; Salvat-Melis M; Renversez JC; McCord G; Boignard A; Carpentier PH; Schwedhelm E
Free Radic Biol Med; 2006 May; 40(10):1732-7. PubMed ID: 16678012
[TBL] [Abstract][Full Text] [Related]
20. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
Wu P; Roberts LJ; Shintani AK; Sheller JR; Minton PA; Higgins SB; Hartert TV
Free Radic Res; 2007 Sep; 41(9):956-62. PubMed ID: 17729112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
